Lunai Bioworks, Inc. (LNAI)
1.93
-0.01
(-0.52%)
USD |
NASDAQ |
Sep 25, 16:00
1.90
-0.03
(-1.55%)
After-Hours: 19:59
Lunai Bioworks Total Assets (Quarterly) : 9.860M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 9.860M |
| December 31, 2025 | 6.666M |
| September 30, 2025 | 6.961M |
| June 30, 2025 | 8.231M |
| March 31, 2025 | 117.73M |
| December 31, 2024 | 111.34M |
| September 30, 2024 | 121.83M |
| June 30, 2024 | 163.13M |
| March 31, 2024 | 178.09M |
| December 31, 2023 | 58.02M |
| September 30, 2023 | 57.56M |
| June 30, 2023 | 58.30M |
| March 31, 2023 | 78.73M |
| December 31, 2022 | 80.27M |
| September 30, 2022 | 83.07M |
| June 30, 2022 | 84.63M |
| March 31, 2022 | 180.10M |
| December 31, 2021 | 183.14M |
| September 30, 2021 | 184.06M |
| June 30, 2021 | 189.61M |
| March 31, 2021 | 173.70M |
| December 31, 2020 | 172.89M |
| September 30, 2020 | 175.13M |
| June 30, 2020 | 178.10M |
| March 31, 2020 | 180.51M |
| Date | Value |
|---|---|
| December 31, 2019 | 178.36M |
| September 30, 2019 | 180.62M |
| June 30, 2019 | 179.88M |
| March 31, 2019 | 169.31M |
| December 31, 2018 | 173.96M |
| September 30, 2018 | 175.80M |
| June 30, 2018 | 179.66M |
| March 31, 2018 | 144.26M |
| December 31, 2017 | 7.827M |
| September 30, 2017 | 3.711M |
| June 30, 2017 | 4.522M |
| March 31, 2017 | 0.3823M |
| December 31, 2016 | 0.431M |
| September 30, 2016 | 0.9447M |
| June 30, 2016 | 0.8708M |
| March 31, 2016 | 0.9805M |
| December 31, 2015 | 1.336M |
| September 30, 2015 | 1.731M |
| June 30, 2015 | |
| March 31, 2015 | 3.643M |
| December 31, 2014 | 5.240M |
| September 30, 2014 | 2.552M |
| June 30, 2014 | 0.7183M |
| March 31, 2014 | |
| December 31, 2013 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
| Imunon, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 19.41M |
| Shareholders Equity (Quarterly) | -9.553M |
| Debt to Equity Ratio | -0.1477 |
| Current Ratio | 0.1936 |
| Net Debt Paydown Yield | 6.80% |